Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACE Combined With Thermal Ablation, ADC, ICI, and Chemotherapy for HER2+ Gastric Cancer With Liver Metastases
NCT07602140Phase 2Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
01
Overview
A Phase 2 trial of disitamab vedotin, sintilimab, tegafur in gastric cancer (GC), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
disitamab vedotinsintilimabtegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07602140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07602140.